All experiments were performed on the same CCM sample, with the outcomes determined by the total protein concentration, Western blotting for the exosome marker CD9, and RT-qPCR analysis of microRNAs (miRNAs) targeting the miRNA-21. This evidence concerns the gene CD9 and cerebral cavernous malformation.